Endava is trading at $1.75, up 6.06%, alongside a broader risk-on session. - The Nasdaq is up 0.76% and the S&P 500 0.42% in the supplied market context. - No confirmed Endava-specific announcement explaining the September 30 move surfaced in the search; the Q4 earnings preview is for October 1, not a reported result. - Reports about the CFO investigation and related shareholder lawsuits concern earlier events, not a new catalyst today.